Copper Bis(thiosemicarbazonato)-stilbenyl Complexes That Bind to Amyloid-β Plaques.
Asif NoorDavid J HayneSinChun LimJessica K Van ZuylekomCarleen CullinanePeter D RoseltCatriona A McLeanJonathan M WhitePaul S DonnellyPublished in: Inorganic chemistry (2020)
Alzheimer's disease is characterized by the presence of extracellular amyloid-β plaques. Positron emission tomography (PET) imaging with tracers radiolabeled with positron-emitting radionuclides that bind to amyloid-β plaques can assist in the diagnosis of Alzheimer's disease. With the goal of designing new imaging agents radiolabeled with positron-emitting copper-64 radionuclides that bind to amyloid-β plaques, a family of bis(thiosemicarbazone) ligands with appended substituted stilbenyl functional groups has been prepared. The ligands form charge-neutral and stable complexes with copper(II). The new ligands can be radiolabeled with copper-64 at room temperature. Two lead complexes were demonstrated to bind to amyloid-β plaques present in post-mortem brain tissue from subjects with clinically diagnosed Alzheimer's disease and crossed the blood-brain barrier in mice. The work presented here provides strategies to prepare compounds with radionuclides of copper that can be used for targeted brain PET imaging.
Keyphrases
- pet imaging
- positron emission tomography
- room temperature
- computed tomography
- oxide nanoparticles
- ionic liquid
- high resolution
- quantum dots
- resting state
- white matter
- type diabetes
- fluorescent probe
- cerebral ischemia
- functional connectivity
- mass spectrometry
- drug delivery
- molecular docking
- subarachnoid hemorrhage
- cancer therapy
- energy transfer
- blood brain barrier